Dannex Ayrton Starwin Plc. (DASPHARMA)

GHS0.41 Jun 03, 2026 +7.89%
Market Cap: N/A
Volume: 110.4K

Key Metrics

Market Cap
--
EPS
₵0.17
P/E Ratio
2.42x
Shares Outstanding
--
Dividend Yield
--
P/B Ratio
--
PEG Ratio
--

Performance

1D
+0.0%
1W
+0.0%
1M
+0.0%
3M
+7.9%
1Y
+7.9%
3Y
+2.5%
5Y
+2.5%
Max
+2.5%

Dividends

Dannex Ayrton Starwin Plc. has not paid any dividends in the last 5 years.

No dividend history available.

Liquidity

Low
Liquidity Score 27/100
Avg Daily Volume
451
Trading Days
245
Zero-Trade Days
138
Inactive Rate
56%
Selling
₵
worth of shares
Estimated time to sell ~2 months
Shares to sell 2,440
% of avg daily volume 541.2%

This exceeds average daily volume — selling may take multiple sessions and could impact price.

Assumes 25% participation rate of daily volume. Actual time may vary.

Based on 245 trading sessions in the selected period.

About Dannex Ayrton Starwin Plc

Dannex Ayrton Starwin Plc (DAS Pharma) is a Ghanaian pharmaceutical and consumer healthcare company formed from the merger of the Dannex, Ayrton, and Starwin businesses. The company manufactures and distributes pharmaceutical products, over-the-counter medicines, and personal care items. DAS Pharma operates manufacturing facilities in Ghana and distributes its products through pharmacies, hospitals, and retail outlets across the country. The company is one of the larger locally-listed pharmaceutical firms on the Ghana Stock Exchange and competes with both domestic manufacturers and imported products in the Ghanaian healthcare market.

Healthcare & Pharmaceuticals
Website
www.daspharma.com.gh

Competitors

Other stocks in the Healthcare & Pharmaceuticals sector.

SymbolPriceDay Change
IILGHS 0.08 0.00 (0.00%)